Utah Patient Data Link Medical Cannabis Use With Lower Opioid Prescribing
Utah study links medical cannabis use to fewer opioid prescriptions among chronic-pain patients, highlighting association—not proof—of opioid-sparing effect.
Utah study links medical cannabis use to fewer opioid prescriptions among chronic-pain patients, highlighting association—not proof—of opioid-sparing effect.
A 2024 analysis of 81,000 medical cannabis patients reveals chronic pain, anxiety and PTSD as top qualifying conditions, with multi-condition patterns.
Could cannabis aid opioid treatment? Augsburg University 2024 thesis treats it as a potential adjunct to withdrawal and pain, but evidence remains preliminary.
CBD: what the science truly supports and what it does not. From purified seizure medicines to uncertain uses, safety, dosing, and product quality.
Learn how California cannabis delivery works: licensed retailers, ID checks, taxes, and limits, plus what can and can't be delivered—order safely.
Australian study finds prescribed medicinal cannabis linked to short-term improvements in pain, mood and sleep—balanced by safety notes and uncertainty.
Discover Alabama's medical cannabis program: limited retail access, new dispensaries, licensing hurdles, and what it means for patients in 2026.
A large New Zealand survey hints cannabis may substitute for alcohol and other drugs for some users, but it stops short of causation or treatment claims.
Unpack what actually helps cannabis detox and what drug tests detect—debunking quick-fix myths and revealing realistic THC-detection timelines.
NIJ awards $516k to improve hemp-vape analysis and hemp-vs-marijuana identification, boosting lab accuracy, labeling checks, and forensic decision tools.